Fresenius : Capital Markets Day 2024

Capital Markets Day 2024

Fresenius Helios

London, June 5, 2024

Visit the Fresenius Capital Markets Day website!

On our website you will find additional information and materials, including the webcast link, the presentation, the Investor News, a Fresenius Helios infographic - as well as a replay and transcript (both available after the event).

Notice on the use of photographs and video recordings

During this event, photos and video recordings of participants will be made. Some photos and/or recordings may possibly be used for future publication and marketing purposes of Fresenius Group and Fresenius Helios. These include the Fresenius Group and the Fresenius Helios websites as well as the Helios Germany and Quirónsalud websites, and Social Media.

For participants on-site: If you do not want to be displayed in any of these media, please inform our colleagues at the registration desk. Please be aware that selecting seats in the front row may result in an identifying photo or video, although primarily featuring the presenters on stage.

Safe Harbor Statement

This presentation contains forward-looking statements that are subject to various risks and uncertainties. Future results could differ materially from those described in these forward-looking statements due to a variety of factors, e.g., changes in business, economic, and competitive conditions, regulatory reforms, results of clinical trials, foreign-exchange-rate fluctuations, uncertainties in litigation or investigative proceedings, the availability of financing, and unforeseen impacts of international conflicts.

Financial figures on profit and profitability throughout this presentation, especially EBIT, EBITDA, and related margins, are generally reported "before special items". Hence, these figures exclude certain one-time effects. Regarding the definition of financial performance indicators, these refer to the most recent financial publications available on the Fresenius corporate website.

Fresenius does not undertake any responsibility to update the forward- looking statements contained in this presentation.

Capital Markets Day 2024

June 5, 2024

AGENDA

Welcome/Opening Remarks	Markus Georgi | Head of Investor Relations	10:30 am - 10:35 am
#FutureFresenius	Michael Sen | CEO Fresenius	10:35 am - 11:00 am
Our Care Provision Platform	Robert Möller | CEO Fresenius Helios & Helios Germany	11:00 am - 11:25 am
Fresenius Helios Financials	Ralph Böttcher | CFO Fresenius Helios	11:25 am - 11:45 am
Q&A	Robert Möller & Ralph Böttcher	11:45 am - 12:15 pm
Coffee Break		12:15 pm - 12:30 pm
Focus on Core Operations:	Robert Möller | CEO Fresenius Helios & Helios Germany	12:30 pm - 01:15 pm
Helios Germany	Olaf Kannt | Medical Consultant Helios Germany
Q&A	Robert Möller & Olaf Kannt	01:15 pm - 01:30 pm
Lunch		01:30 pm - 02:30 pm
Focus on Core Operations:	Víctor Madera | Founder & CEO Quirónsalud	02:30 pm - 03:15 pm
Quirónsalud	Juan Antonio Álvaro de la Parra | COO Quirónsalud
Q&A	Víctor Madera & Juan Antonio Álvaro de la Parra	03:15 pm - 03:30 pm
Q&A	All	03:30 pm - 03:45 pm

Closing Remarks

Michael Sen

03:45 pm - 04:00 pm

Today's Presenters

Michael Sen

Chairman of the Management Board

Fresenius Management SE

Michael Sen became Chairman of the Management Board of Fresenius (equivalent to President and CEO) on October 1, 2022.

He joined Fresenius in April 2021 as Chairman of the Management Board of Fresenius Kabi. Before joining Fresenius Kabi, Michael Sen was a member of the Management Board of Siemens AG, where he was responsible for the healthcare business Siemens Healthineers and for Siemens' energy business. Prior to that, he was Chief Financial Officer of E.ON SE. At the start of his professional career, Michael Sen completed an apprenticeship at Siemens in Berlin and then studied business administration at the Technical University of Berlin.

Today's Presenters

Robert Möller	Ralph Böttcher
CEO Fresenius Helios	CFO
Fresenius Helios and Helios Germany	Fresenius Helios

Robert Möller joined the Management Board of Fresenius in September 2023 with responsibility for Fresenius Helios.

Robert Möller has been CEO of Helios Kliniken GmbH since 2022. He joined Helios in 2014, where he held the position of Clinic Managing Director at Helios Hanseklinikum Stralsund until 2017. After a short time away, he returned to Helios in 2019 and took over the management of various regions. Möller studied human medicine at the University of Hamburg and practiced as a specialist for internal medicine. After various medical positions and a part-time master's degree in health care management, he switched to hospital management while continuing to work as a physician.

Ralph Böttcher joined Fresenius Helios as Chief Financial Officer in September 2023, being in charge of Finance, Governance, Data Protection, IT and Cybersecurity.

Before joining Fresenius Helios, Ralph had gained a wealth of experience in senior finance roles in multinational companies and various industries while being based in Germany, Spain, Italy, and South Africa. He is an alumni of FAU University Erlangen- Nürnberg, where he received his MBA as well as a diploma in Political Science, and IESE Business School in Barcelona where he completed the Advanced Management Program.

Today's Presenters

Víctor Madera Núñez	Juan Antonio Álvaro de la Parra
Founder and CEO	COO
Quirónsalud	Quirónsalud

Víctor Madera Núñez has been Chief Executive Officer of Quirónsalud since January 2023.

He has played a key role in the creation and rapid growth of the group since he founded one of its predecessors in the late 1990s. For many years, he headed the leadership team as President, and helped to create what has become Spain´s leading private healthcare operator. In 2017, following the acquisition of Quirónsalud by Fresenius, he became President of the Board of Directors of Quirónsalud. Víctor is a trained physician with a focus on sports medicine.

Juan Antonio Álvaro de la Parra has been the Chief Operating Officer of Quirónsalud since the beginning of 2023.

He has more than 25 years of experience of successfully managing hospitals in the Madrid region. In 2005 he became the general manager of Fundación Jiménez Díaz, the flagship hospital of Quirónsalud and one of the most renowned healthcare institutions in Spain. In 2008 he was promoted regional manager for the group's hospitals in Madrid. Before he became a hospital manager, he worked several years as a financial auditor. He has a degree in economics from the Autonomous University of Madrid.

Today's Presenters

Dr. Olaf Kannt

Medical Consultant

Helios Germany

Dr. Olaf Kannt joined Helios Germany in 2004. In his role as Medical Consultant to the Helios Germany Group Management Board, he is responsible for the company's medical strategy and for driving medical specialization through hospital clusters.

Dr. Olaf Kannt has held various management positions within Helios Germany. Since February 2022, he has also been responsible for all medical matters in the company's South and North regions. He holds several academic positions, such as being a Professor of Health Economics at Medical School Hamburg (MSH) and has been involved in various medical committees, associations, and quality assurance initiatives, as well as teaching functions. He has a medical degree from the University of Greifswald, an MBA degree from the University of Potsdam, and a certificate in tropical medicine from the University of Leipzig. He is a pediatrician, neonatologist, neuropediatrician, and a sleep medicine specialist.

#FutureFresenius

Michael Sen, CEO Fresenius Helios CMD - June 5, 2024

A stronger and simpler company

2